Autologous Stem/Stromal Cells in Neurological Disorders and Disease

Inclusion Criteria: * Documented Functional Neurological Damage To Central or Peripheral Nervous System Unlikely To Improve With Present Standard of Care Approaches * At least 6 months after onset or diagnosis of disease process * Current Medical therapy for the condition is either failing or not tolerated by patient * Patient must be capable of interval neurologic exams with investigators or their own neurologic specialists * Patient must be capable and determined competent to provide detailed informed consent for study participation * In estimation of investigators, that there are minimal or no significant risk of harm to general health or conditions for collection of autologous stem cell collection and use Exclusion Criteria: * Inability of patient to have diagnostic examinations or studies (MRI) to evaluate and document the disease state or unwilling/unable to cooperate with such documentation * Patients not medically stable, or whom may have ongoing conditions which increases may place the patient at significant risk of major complications, to be determined by investigator or patient's medical provider or neurologic specialists * History of active cancer or ongoing anticancer therapy within six months of such care * Women of childbearing age must not be pregnant at the time of treatment, and should refrain from becoming pregnant of at minimum of 3 month after study treatment